Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -73.72%45.37M | ---- | 250.46%172.65M | ---- | -410.08%-114.75M | ---- | -62.75%37.01M | ---- | 25.17%99.35M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -5.41%-6.8M | ---- | -12.79%-6.45M | ---- | -11.27%-5.72M | ---- | -7.38%-5.14M | ---- | 58.85%-4.79M |
| Attributable subsidiary (profit) loss | ---- | 814.63%27.63M | ---- | -1.44%3.02M | ---- | 139.35%3.07M | ---- | 24.93%-7.79M | ---- | 26.27%-10.38M |
| Impairment and provisions: | ---- | -27.49%79.85M | ---- | -20.47%110.13M | ---- | 115.58%138.48M | ---- | 59.02%64.23M | ---- | -37.25%40.39M |
| -Impairment of trade receivables (reversal) | ---- | -23.47%77.62M | ---- | -26.76%101.43M | ---- | 115.58%138.48M | ---- | 59.02%64.23M | ---- | -37.25%40.39M |
| -Other impairments and provisions | ---- | -74.44%2.22M | ---- | --8.7M | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | 444.19%296K | ---- | -137.23%-86K | ---- | 313.89%231K | ---- | -247.95%-108K | ---- | 191.25%73K |
| -Loss (gain) from selling other assets | ---- | 444.19%296K | ---- | -137.23%-86K | ---- | 313.89%231K | ---- | -247.95%-108K | ---- | 191.25%73K |
| Depreciation and amortization: | ---- | 16.31%15.25M | ---- | 1.16%13.11M | ---- | 130.06%12.96M | ---- | 12.06%5.63M | ---- | -28.84%5.03M |
| -Depreciation | ---- | 6.70%13.45M | ---- | 1.12%12.61M | ---- | 137.95%12.47M | ---- | 12.47%5.24M | ---- | -30.43%4.66M |
| -Other depreciation and amortization | ---- | 257.57%1.8M | ---- | 2.24%502K | ---- | 24.94%491K | ---- | 6.79%393K | ---- | 0.00%368K |
| Financial expense | ---- | -7.68%60.13M | ---- | -6.79%65.13M | ---- | 83.86%69.88M | ---- | -0.15%38.01M | ---- | -7.46%38.07M |
| Exchange Loss (gain) | ---- | 229.24%912K | ---- | -92.08%277K | ---- | 1,048.24%3.5M | ---- | -115.82%-369K | ---- | 440.58%2.33M |
| Special items | ---- | -32.04%-4.62M | ---- | 0.00%-3.5M | ---- | 13.14%-3.5M | ---- | -12.75%-4.03M | ---- | -190.50%-3.58M |
| Operating profit before the change of operating capital | ---- | -38.46%218.01M | ---- | 240.19%354.28M | ---- | -18.28%104.14M | ---- | -23.46%127.44M | ---- | 1.38%166.51M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 173.94%13.11M | ---- | -7,711.01%-17.73M | ---- | -103.59%-227K | ---- | 139.96%6.32M | ---- | -137.89%-15.82M |
| Accounts receivable (increase)decrease | ---- | -118.10%-644.44M | ---- | -2.93%-295.48M | ---- | 19.01%-287.07M | ---- | -160.12%-354.45M | ---- | -436.85%-136.26M |
| Accounts payable increase (decrease) | ---- | 142.18%258.88M | ---- | 359.38%106.9M | ---- | -125.83%-41.21M | ---- | -25.59%159.56M | ---- | 392.27%214.42M |
| prepayments (increase)decrease | ---- | -116.00%-14.93M | ---- | 213.89%93.35M | ---- | -693.75%-81.96M | ---- | 31.95%-10.33M | ---- | -1,110.93%-15.17M |
| Special items for working capital changes | ---- | 1,777.44%166.03M | ---- | -102.34%-9.9M | ---- | 4,531.35%423.81M | ---- | 82.28%-9.56M | ---- | 62.94%-53.99M |
| Cash from business operations | 126.36%38.96M | -101.44%-3.34M | -539.45%-147.8M | 96.98%231.42M | 79.21%-23.11M | 245.02%117.48M | -45.60%-111.16M | -150.73%-81.02M | -40.12%-76.35M | 99.62%159.69M |
| Other taxs | 42.16%-20.24M | -293.57%-38.92M | -439.28%-34.99M | 45.48%-9.89M | 63.52%-6.49M | 12.39%-18.14M | 11.02%-17.79M | -4.59%-20.7M | -2.51%-19.99M | 50.35%-19.79M |
| Net cash from operations | 110.24%18.72M | -119.07%-42.26M | -517.50%-182.79M | 122.98%221.53M | 77.04%-29.6M | 197.67%99.35M | -33.85%-128.95M | -172.71%-101.72M | -30.21%-96.34M | 248.62%139.9M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 29.59%911K | 0.29%1.05M | 46.46%703K | -81.44%1.04M | -91.10%480K | -41.38%5.63M | 50.33%5.39M | 1,307.04%9.6M | 580.83%3.59M | 77.14%682K |
| Dividend received - investment | ---- | --450K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | 36.60%-21.08M | -97.90%10.38M | -116.33%-33.26M | 865.77%493.14M | -5.93%203.62M | -416.42%-64.4M | 69,920.65%216.44M | -127.06%-12.47M | -100.67%-310K | 200.00%46.08M |
| Acquisition of subsidiaries | ---- | ---84.62M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | -84.57%50K | -78.70%193K | -76.30%324K | 33.24%906K | 3,497.37%1.37M | 7.59%680K | 3,900.00%38K | 20.38%632K | 98.00%-1K | -68.10%525K |
| Cash on investment | -346.58%-18.48M | 41.56%-7.1M | 21.00%-4.14M | 53.13%-12.15M | 64.17%-5.24M | -633.47%-25.93M | -2,323.88%-14.62M | 88.22%-3.54M | 93.59%-603K | 37.56%-30.02M |
| Other items in the investment business | ---- | ---- | ---- | ---317.96M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -6.13%-38.6M | -148.28%-79.65M | -118.16%-36.37M | 296.35%164.98M | -3.39%200.23M | -1,354.41%-84.02M | 7,650.93%207.26M | -133.46%-5.78M | -92.80%2.67M | 119.97%17.27M |
| Net cash before financing | 90.93%-19.88M | -131.54%-121.91M | -228.44%-219.16M | 2,422.04%386.5M | 117.89%170.62M | 114.26%15.33M | 183.61%78.31M | -168.40%-107.5M | -154.22%-93.67M | 439.15%157.16M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 30.78%1.43B | -12.59%1.71B | -17.09%1.09B | 26.64%1.95B | 29.65%1.32B | 164.32%1.54B | 174.19%1.01B | -8.32%583.8M | 28.05%370.05M | -11.72%636.77M |
| Refund | -42.69%-1.44B | 29.40%-1.61B | 35.19%-1.01B | -68.22%-2.28B | -46.11%-1.55B | -119.42%-1.36B | -182.63%-1.06B | 9.19%-618.6M | -39.38%-376.22M | -8.08%-681.19M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --91.66M | --91.66M | ---- |
| Interest paid - financing | -36.55%-32.1M | 12.80%-57.7M | 30.36%-23.5M | -4.41%-66.17M | -6.09%-33.75M | -75.95%-63.37M | -40.06%-31.82M | 3.06%-36.02M | -23.02%-22.72M | 9.38%-37.16M |
| Dividends paid - financing | ---- | ---4.08M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Absorb investment income | ---- | -97.71%200K | -97.71%200K | 819.58%8.74M | --8.74M | --950K | ---- | ---- | ---- | -98.00%4M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 3.74%-3.78M | -147.03%-3.78M | -10.30%-3.93M |
| Other items of the financing business | -198.28%-11.3M | 163.91%4.55M | 113.62%11.5M | -67.51%-7.12M | 149.81%5.38M | 2.52%-4.25M | -111.82%-10.8M | -32.12%-4.36M | -292.31%-5.1M | 98.30%-3.3M |
| Net cash from financing operations | -179.69%-55.73M | 108.65%34.27M | 126.92%69.94M | -441.56%-396.33M | -179.75%-259.81M | 1,087.43%116.04M | -274.07%-92.87M | 111.26%9.77M | 32,235.76%53.35M | -234.66%-86.77M |
| Effect of rate | -425.00%-13K | 600.00%14K | -20.00%4K | 0.00%2K | 150.00%5K | 200.00%2K | 140.00%2K | 81.82%-2K | -200.00%-5K | -103.83%-11K |
| Net Cash | 49.33%-75.61M | -791.56%-87.64M | -67.32%-149.22M | -107.48%-9.83M | -512.42%-89.18M | 234.42%131.36M | 63.88%-14.56M | -238.82%-97.72M | -9.90%-40.31M | 288.95%70.39M |
| Begining period cash | -41.65%122.78M | -4.46%210.41M | -4.46%210.41M | 147.81%220.23M | 147.81%220.23M | -38.80%88.87M | -38.28%88.87M | 97.27%145.22M | 95.61%144M | 33.29%73.62M |
| Cash at the end | -22.93%47.16M | -41.65%122.78M | -53.31%61.19M | -4.46%210.41M | 76.37%131.06M | 363.70%220.23M | -28.33%74.31M | -67.02%47.5M | 180.67%103.68M | 95.61%144M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.